Don't Miss

New Report

Defending Against Biosimilars: Originator strategies

Protecting your biologics business in a high stakes market

Based on in-depth interviews with eight biologics experts from leading biotechnology, consulting, marketing and healthcare-associated companies. Taking perspectives from both the US and EU, this report delves into the threats facing the biologics marketplace and identifies what must happen for biologics companies to not only survive, but effectively compete and ultimately thrive.
Battle of the biologics: How to survive >>

Insight, Analysis and Views

Corbus unveils mid-stage study data for investigational cystic fibrosis drug anabasum

My News

Upgrade your subscription to get more features!

Conference News

Latest News